104 related articles for article (PubMed ID: 27311012)
21. Cell lines of hyperdiploid myeloma, are we there yet?
Chng WJ; Fonseca R
Br J Haematol; 2008 Mar; 140(5):579-80; author reply 580-1. PubMed ID: 18028478
[No Abstract] [Full Text] [Related]
22. [Cytogenetic and molecular basis of multiple myeloma].
Taniwaki M; Matsumoto Y
Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
[TBL] [Abstract][Full Text] [Related]
23. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
24. [DNA content and cell cycle analysis of myeloma cells in patients with multiple myeloma].
Sun WL; Wu YJ; Wang X; Li H; Zhuang JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):824-8. PubMed ID: 18718069
[TBL] [Abstract][Full Text] [Related]
25. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
[TBL] [Abstract][Full Text] [Related]
28. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
[TBL] [Abstract][Full Text] [Related]
29. [Karyotypic variability of human myeloma cell lines].
Turilova VK; Smirnova TD
Tsitologiia; 2012; 54(8):621-36. PubMed ID: 23074853
[TBL] [Abstract][Full Text] [Related]
30. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
[TBL] [Abstract][Full Text] [Related]
31. Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric study.
Shimazaki C; Gotoh H; Oku N; Ashihara E; Inaba T; Murakami S; Ura Y; Nakagawa M; Fujita N
Acta Haematol; 1992; 88(2-3):86-91. PubMed ID: 1466204
[TBL] [Abstract][Full Text] [Related]
32. [Molecular genetic methods for the prognostic criteria in multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2005 Aug; 146(32):1673-82. PubMed ID: 16149245
[TBL] [Abstract][Full Text] [Related]
33. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.
Drexler HG; Matsuo Y
Leuk Res; 2000 Aug; 24(8):681-703. PubMed ID: 10936422
[TBL] [Abstract][Full Text] [Related]
34. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
36. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
37. Biology and therapy of multiple myeloma.
Barlogie B; Alexanian R
Acta Haematol; 1987; 78 Suppl 1():171-4. PubMed ID: 3124442
[TBL] [Abstract][Full Text] [Related]
38. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
39. Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.
Otsuki T; Hata H; Harada N; Matsuzaki H; Yata K; Wada H; Yawata Y; Ueki A; Yamada O
Int J Hematol; 2000 Aug; 72(2):216-22. PubMed ID: 11039672
[TBL] [Abstract][Full Text] [Related]
40. Establishment and biological characteristics of human multiple myeloma cell line CZ-1.
Hou J; Lin FY; Zhang B; Zhang LZ; Ding SQ
Chin Med J (Engl); 2004 Jan; 117(1):115-9. PubMed ID: 14733786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
